Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Issa

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Medchemcomm|August 16, 2018
Withaferin A induces cell death and differentiation in multiple myeloma cancer stem cellsMark E Issa, Muriel Cuendet
Journal of Cellular Immunology|June 13, 2022
Glycogen Synthase Kinase-3 (GSK-3) Regulation of Inhibitory Coreceptor Expression in T-cell ImmunityMark E Issa, Christopher E Rudd
Planta Medica|May 5, 2017
Targeting Multiple Myeloma Cancer Stem Cells with Natural Products - Lessons from Other Hematological MalignanciesMark E Issa, Sylvian Cretton, Muriel Cuendet
Biochimica Et Biophysica Acta. Reviews on Cancer|May 10, 2026
Reprogramming regulatory T cell plasticity for cancer immunotherapyMark E Issa, Alejandro Schcolnik-Cabrera, Rosanna Monetta
Planta Medica|March 15, 2018
A Bivalent Role of Genistein in Sprouting AngiogenesisSarah Berndt, Mark E Issa, Gilles Carpentier, et al.
Cancer Metastasis Reviews|March 26, 2024
Glioblastoma stem cell metabolism and immunityJoseph Hawly, Micaela G Murcar, Alejandro Schcolnik-Cabrera, et al.
Cancer Biology & Therapy|July 20, 2016
Bruceantin inhibits multiple myeloma cancer stem cell proliferationMark E Issa, Sarah Berndt, Gilles Carpentier, et al.
Frontiers in Pharmacology|September 26, 2017
Withanolide D Exhibits Similar Cytostatic Effect in Drug-Resistant and Drug-Sensitive Multiple Myeloma CellsMark E Issa, E M K Wijeratne, A A L Gunatilaka, et al.
Frontiers in Oncology|December 4, 2023
Similarities and divergences in the metabolism of immune cells in cancer and helminthic infectionsDiego Esperante, Mónica Itzel Martínez Gutiérrez, Mark E Issa, et al.
Clinical Epigenetics|February 17, 2017
Epigenetic strategies to reverse drug resistance in heterogeneous multiple myelomaMark E Issa, Farnaz Sedigheh Takhsha, Chandra Sekhar Chirumamilla, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Medchemcomm|August 16, 2018
Withaferin A induces cell death and differentiation in multiple myeloma cancer stem cellsMark E Issa, Muriel Cuendet
Journal of Cellular Immunology|June 13, 2022
Glycogen Synthase Kinase-3 (GSK-3) Regulation of Inhibitory Coreceptor Expression in T-cell ImmunityMark E Issa, Christopher E Rudd
Planta Medica|May 5, 2017
Targeting Multiple Myeloma Cancer Stem Cells with Natural Products - Lessons from Other Hematological MalignanciesMark E Issa, Sylvian Cretton, Muriel Cuendet
Biochimica Et Biophysica Acta. Reviews on Cancer|May 10, 2026
Reprogramming regulatory T cell plasticity for cancer immunotherapyMark E Issa, Alejandro Schcolnik-Cabrera, Rosanna Monetta
Planta Medica|March 15, 2018
A Bivalent Role of Genistein in Sprouting AngiogenesisSarah Berndt, Mark E Issa, Gilles Carpentier, et al.
Cancer Metastasis Reviews|March 26, 2024
Glioblastoma stem cell metabolism and immunityJoseph Hawly, Micaela G Murcar, Alejandro Schcolnik-Cabrera, et al.
Cancer Biology & Therapy|July 20, 2016
Bruceantin inhibits multiple myeloma cancer stem cell proliferationMark E Issa, Sarah Berndt, Gilles Carpentier, et al.
Frontiers in Pharmacology|September 26, 2017
Withanolide D Exhibits Similar Cytostatic Effect in Drug-Resistant and Drug-Sensitive Multiple Myeloma CellsMark E Issa, E M K Wijeratne, A A L Gunatilaka, et al.
Frontiers in Oncology|December 4, 2023
Similarities and divergences in the metabolism of immune cells in cancer and helminthic infectionsDiego Esperante, Mónica Itzel Martínez Gutiérrez, Mark E Issa, et al.
Clinical Epigenetics|February 17, 2017
Epigenetic strategies to reverse drug resistance in heterogeneous multiple myelomaMark E Issa, Farnaz Sedigheh Takhsha, Chandra Sekhar Chirumamilla, et al.
Pageof 2